Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines
The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from Erwinia carotovora (ECAR LANS) and Escherichia coli (MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lin...
Gespeichert in:
Veröffentlicht in: | Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry Biomedical chemistry, 2012-10, Vol.6 (4), p.307-316 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 316 |
---|---|
container_issue | 4 |
container_start_page | 307 |
container_title | Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry |
container_volume | 6 |
creator | Abakumova, O. Yu Podobed, O. V. Karalkin, P. A. Kondakova, L. I. Sokolov, N. N. |
description | The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from
Erwinia carotovora
(ECAR LANS) and
Escherichia coli
(MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lines (Jurkat, Jurkat/A4, Molt-4), human chronic myeloid leukemia K562 cells, human promyelocytic leukemia HL-60, and also human solid tumor cells (prostate carcinoma LnCap, breast adenocarcinoma MCF7, ovarian adenocarcinoma SCOV-3 and carcinoma CaOV, hepatocarcinoma Hep G2, fibrosarcoma HT-1080) and animal solid tumor cells (rat Gasser’s ganglion neurinoma cells GGNC-1, mouse glioblastoma EPNT-5). We investigated sensitivity of tumor cells (seeded at different density) to L-asparaginases, as well the effect of L-asparaginases on cell growth rate, protein and DNA synthesis in the presence of various cytostatics. Cell cycle analysis by flow cytofluorimetry and detection of apoptotic cells before and after treatment with L-asparaginases indicate that ECAR LANS L-asparaginase suppressed growth of all tested solid tumor cells. Evaluation of leukemic cell number after treatment with L-asparaginases for 24, 48 and 72 h demonstrated that asparagine deficiency did not kill cells but stopped normal cell division. The cytofluorometric study of solid and leukemic cells revealed that except HL-60 cells the treatment with L-asparaginase for 72 h did not change cell cycle phase distribution and did not increase the number of apoptotic cells. Combined treatment of cells using a combination of L-asparaginase and doxorubicin significantly increased the number of apoptotic cells up to 60% (MCF-7 cells), 40% (Jurkat cells) and even 99% (HL-60). High levels of DNA and protein synthesis rates in asparaginase-treated tumor cells suggest lack of massive entry of tumor cells to apoptosis. This conclusion is based on the fact of sensitivity of multi-resistant Jurkat/A4 cells to L-asparaginases (it is nearly impossible to induce apoptosis in these cells). Since ECAR LANS did not influence growth of normal human fibroblasts it appears that the enzyme cytotoxicity is associated only asparagine deficiency. |
doi_str_mv | 10.1134/S1990750812040026 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1285088704</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2815149431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c349t-f9c288fefbe5e3b82b245b19a702595de8497f585872e9d944eb4f409647327f3</originalsourceid><addsrcrecordid>eNp1kU1PxCAQhhujibr6A7yRePFSBQoLHI3xK9nEg3puaDusrC2sQDV79o_LusYYjQcyZHjed4aZojgi-JSQip3dE6Ww4FgSihnGdLpV7K1TpeBkuv19x3K32I9xgfGUVIrtFe_nLtk0Dj4g3Sb7atMKeYNmpY5LHfTcOh0BmeAHdBnerLMatTr45F990EjPtXUxoc4aAwFcQk_joB3SrsvHDrpHPYzPMNj2Mxd9bzu0KddCn1-tg3hQ7BjdRzj8ipPi8ery4eKmnN1d316cz8q2YiqVRrVUSgOmAQ5VI2lDGW-I0gJTrngHkilhuORSUFCdYgwaZhhWUyYqKkw1KU42vsvgX0aIqR5sXLehHfgx1oTKPCApMMvo8S904cfgcnc1IZwIpQhRmSIbqg0-xgCmXob86bCqCa7Xa6n_rCVr6EYTM-vmEH44_yv6ALL2j_M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1151799119</pqid></control><display><type>article</type><title>Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines</title><source>SpringerLink Journals - AutoHoldings</source><creator>Abakumova, O. Yu ; Podobed, O. V. ; Karalkin, P. A. ; Kondakova, L. I. ; Sokolov, N. N.</creator><creatorcontrib>Abakumova, O. Yu ; Podobed, O. V. ; Karalkin, P. A. ; Kondakova, L. I. ; Sokolov, N. N.</creatorcontrib><description>The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from
Erwinia carotovora
(ECAR LANS) and
Escherichia coli
(MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lines (Jurkat, Jurkat/A4, Molt-4), human chronic myeloid leukemia K562 cells, human promyelocytic leukemia HL-60, and also human solid tumor cells (prostate carcinoma LnCap, breast adenocarcinoma MCF7, ovarian adenocarcinoma SCOV-3 and carcinoma CaOV, hepatocarcinoma Hep G2, fibrosarcoma HT-1080) and animal solid tumor cells (rat Gasser’s ganglion neurinoma cells GGNC-1, mouse glioblastoma EPNT-5). We investigated sensitivity of tumor cells (seeded at different density) to L-asparaginases, as well the effect of L-asparaginases on cell growth rate, protein and DNA synthesis in the presence of various cytostatics. Cell cycle analysis by flow cytofluorimetry and detection of apoptotic cells before and after treatment with L-asparaginases indicate that ECAR LANS L-asparaginase suppressed growth of all tested solid tumor cells. Evaluation of leukemic cell number after treatment with L-asparaginases for 24, 48 and 72 h demonstrated that asparagine deficiency did not kill cells but stopped normal cell division. The cytofluorometric study of solid and leukemic cells revealed that except HL-60 cells the treatment with L-asparaginase for 72 h did not change cell cycle phase distribution and did not increase the number of apoptotic cells. Combined treatment of cells using a combination of L-asparaginase and doxorubicin significantly increased the number of apoptotic cells up to 60% (MCF-7 cells), 40% (Jurkat cells) and even 99% (HL-60). High levels of DNA and protein synthesis rates in asparaginase-treated tumor cells suggest lack of massive entry of tumor cells to apoptosis. This conclusion is based on the fact of sensitivity of multi-resistant Jurkat/A4 cells to L-asparaginases (it is nearly impossible to induce apoptosis in these cells). Since ECAR LANS did not influence growth of normal human fibroblasts it appears that the enzyme cytotoxicity is associated only asparagine deficiency.</description><identifier>ISSN: 1990-7508</identifier><identifier>EISSN: 1990-7516</identifier><identifier>DOI: 10.1134/S1990750812040026</identifier><language>eng</language><publisher>Dordrecht: SP MAIK Nauka/Interperiodica</publisher><subject>Acute lymphatic leukemia ; Adenocarcinoma ; Antitumor activity ; Apoptosis ; Asparagine ; Biochemistry ; Bioorganic Chemistry ; Cancer ; Cell cycle ; Cell division ; Cell number ; Chemistry ; Chemistry and Materials Science ; Chemotherapy ; Chronic myeloid leukemia ; Cytotoxicity ; Deoxyribonucleic acid ; DNA ; DNA biosynthesis ; Doxorubicin ; Enzymes ; Erwinia carotovora ; Escherichia coli ; Fibroblasts ; Fibrosarcoma ; Glioblastoma ; Growth rate ; L-asparaginase ; Leukemia ; Lymphocytes T ; Medicinal Chemistry ; Promyeloid leukemia ; prostate carcinoma ; Protein biosynthesis ; Protein synthesis ; Solid tumors ; Tumor cell lines ; Tumor cells</subject><ispartof>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry, 2012-10, Vol.6 (4), p.307-316</ispartof><rights>Pleiades Publishing, Ltd. 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c349t-f9c288fefbe5e3b82b245b19a702595de8497f585872e9d944eb4f409647327f3</citedby><cites>FETCH-LOGICAL-c349t-f9c288fefbe5e3b82b245b19a702595de8497f585872e9d944eb4f409647327f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S1990750812040026$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S1990750812040026$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Abakumova, O. Yu</creatorcontrib><creatorcontrib>Podobed, O. V.</creatorcontrib><creatorcontrib>Karalkin, P. A.</creatorcontrib><creatorcontrib>Kondakova, L. I.</creatorcontrib><creatorcontrib>Sokolov, N. N.</creatorcontrib><title>Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines</title><title>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry</title><addtitle>Biochem. Moscow Suppl. Ser. B</addtitle><description>The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from
Erwinia carotovora
(ECAR LANS) and
Escherichia coli
(MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lines (Jurkat, Jurkat/A4, Molt-4), human chronic myeloid leukemia K562 cells, human promyelocytic leukemia HL-60, and also human solid tumor cells (prostate carcinoma LnCap, breast adenocarcinoma MCF7, ovarian adenocarcinoma SCOV-3 and carcinoma CaOV, hepatocarcinoma Hep G2, fibrosarcoma HT-1080) and animal solid tumor cells (rat Gasser’s ganglion neurinoma cells GGNC-1, mouse glioblastoma EPNT-5). We investigated sensitivity of tumor cells (seeded at different density) to L-asparaginases, as well the effect of L-asparaginases on cell growth rate, protein and DNA synthesis in the presence of various cytostatics. Cell cycle analysis by flow cytofluorimetry and detection of apoptotic cells before and after treatment with L-asparaginases indicate that ECAR LANS L-asparaginase suppressed growth of all tested solid tumor cells. Evaluation of leukemic cell number after treatment with L-asparaginases for 24, 48 and 72 h demonstrated that asparagine deficiency did not kill cells but stopped normal cell division. The cytofluorometric study of solid and leukemic cells revealed that except HL-60 cells the treatment with L-asparaginase for 72 h did not change cell cycle phase distribution and did not increase the number of apoptotic cells. Combined treatment of cells using a combination of L-asparaginase and doxorubicin significantly increased the number of apoptotic cells up to 60% (MCF-7 cells), 40% (Jurkat cells) and even 99% (HL-60). High levels of DNA and protein synthesis rates in asparaginase-treated tumor cells suggest lack of massive entry of tumor cells to apoptosis. This conclusion is based on the fact of sensitivity of multi-resistant Jurkat/A4 cells to L-asparaginases (it is nearly impossible to induce apoptosis in these cells). Since ECAR LANS did not influence growth of normal human fibroblasts it appears that the enzyme cytotoxicity is associated only asparagine deficiency.</description><subject>Acute lymphatic leukemia</subject><subject>Adenocarcinoma</subject><subject>Antitumor activity</subject><subject>Apoptosis</subject><subject>Asparagine</subject><subject>Biochemistry</subject><subject>Bioorganic Chemistry</subject><subject>Cancer</subject><subject>Cell cycle</subject><subject>Cell division</subject><subject>Cell number</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Chemotherapy</subject><subject>Chronic myeloid leukemia</subject><subject>Cytotoxicity</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA biosynthesis</subject><subject>Doxorubicin</subject><subject>Enzymes</subject><subject>Erwinia carotovora</subject><subject>Escherichia coli</subject><subject>Fibroblasts</subject><subject>Fibrosarcoma</subject><subject>Glioblastoma</subject><subject>Growth rate</subject><subject>L-asparaginase</subject><subject>Leukemia</subject><subject>Lymphocytes T</subject><subject>Medicinal Chemistry</subject><subject>Promyeloid leukemia</subject><subject>prostate carcinoma</subject><subject>Protein biosynthesis</subject><subject>Protein synthesis</subject><subject>Solid tumors</subject><subject>Tumor cell lines</subject><subject>Tumor cells</subject><issn>1990-7508</issn><issn>1990-7516</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kU1PxCAQhhujibr6A7yRePFSBQoLHI3xK9nEg3puaDusrC2sQDV79o_LusYYjQcyZHjed4aZojgi-JSQip3dE6Ww4FgSihnGdLpV7K1TpeBkuv19x3K32I9xgfGUVIrtFe_nLtk0Dj4g3Sb7atMKeYNmpY5LHfTcOh0BmeAHdBnerLMatTr45F990EjPtXUxoc4aAwFcQk_joB3SrsvHDrpHPYzPMNj2Mxd9bzu0KddCn1-tg3hQ7BjdRzj8ipPi8ery4eKmnN1d316cz8q2YiqVRrVUSgOmAQ5VI2lDGW-I0gJTrngHkilhuORSUFCdYgwaZhhWUyYqKkw1KU42vsvgX0aIqR5sXLehHfgx1oTKPCApMMvo8S904cfgcnc1IZwIpQhRmSIbqg0-xgCmXob86bCqCa7Xa6n_rCVr6EYTM-vmEH44_yv6ALL2j_M</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Abakumova, O. Yu</creator><creator>Podobed, O. V.</creator><creator>Karalkin, P. A.</creator><creator>Kondakova, L. I.</creator><creator>Sokolov, N. N.</creator><general>SP MAIK Nauka/Interperiodica</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20121001</creationdate><title>Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines</title><author>Abakumova, O. Yu ; Podobed, O. V. ; Karalkin, P. A. ; Kondakova, L. I. ; Sokolov, N. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c349t-f9c288fefbe5e3b82b245b19a702595de8497f585872e9d944eb4f409647327f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute lymphatic leukemia</topic><topic>Adenocarcinoma</topic><topic>Antitumor activity</topic><topic>Apoptosis</topic><topic>Asparagine</topic><topic>Biochemistry</topic><topic>Bioorganic Chemistry</topic><topic>Cancer</topic><topic>Cell cycle</topic><topic>Cell division</topic><topic>Cell number</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Chemotherapy</topic><topic>Chronic myeloid leukemia</topic><topic>Cytotoxicity</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA biosynthesis</topic><topic>Doxorubicin</topic><topic>Enzymes</topic><topic>Erwinia carotovora</topic><topic>Escherichia coli</topic><topic>Fibroblasts</topic><topic>Fibrosarcoma</topic><topic>Glioblastoma</topic><topic>Growth rate</topic><topic>L-asparaginase</topic><topic>Leukemia</topic><topic>Lymphocytes T</topic><topic>Medicinal Chemistry</topic><topic>Promyeloid leukemia</topic><topic>prostate carcinoma</topic><topic>Protein biosynthesis</topic><topic>Protein synthesis</topic><topic>Solid tumors</topic><topic>Tumor cell lines</topic><topic>Tumor cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abakumova, O. Yu</creatorcontrib><creatorcontrib>Podobed, O. V.</creatorcontrib><creatorcontrib>Karalkin, P. A.</creatorcontrib><creatorcontrib>Kondakova, L. I.</creatorcontrib><creatorcontrib>Sokolov, N. N.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abakumova, O. Yu</au><au>Podobed, O. V.</au><au>Karalkin, P. A.</au><au>Kondakova, L. I.</au><au>Sokolov, N. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines</atitle><jtitle>Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry</jtitle><stitle>Biochem. Moscow Suppl. Ser. B</stitle><date>2012-10-01</date><risdate>2012</risdate><volume>6</volume><issue>4</issue><spage>307</spage><epage>316</epage><pages>307-316</pages><issn>1990-7508</issn><eissn>1990-7516</eissn><abstract>The dose- and time-dependent antitumor and cytotoxic effects of L-asparaginases from
Erwinia carotovora
(ECAR LANS) and
Escherichia coli
(MEDAC) have been investigated using human leukemic cells and human and animal solid tumor cells. These included human T-cell acute lymphoblastic leukemia cell lines (Jurkat, Jurkat/A4, Molt-4), human chronic myeloid leukemia K562 cells, human promyelocytic leukemia HL-60, and also human solid tumor cells (prostate carcinoma LnCap, breast adenocarcinoma MCF7, ovarian adenocarcinoma SCOV-3 and carcinoma CaOV, hepatocarcinoma Hep G2, fibrosarcoma HT-1080) and animal solid tumor cells (rat Gasser’s ganglion neurinoma cells GGNC-1, mouse glioblastoma EPNT-5). We investigated sensitivity of tumor cells (seeded at different density) to L-asparaginases, as well the effect of L-asparaginases on cell growth rate, protein and DNA synthesis in the presence of various cytostatics. Cell cycle analysis by flow cytofluorimetry and detection of apoptotic cells before and after treatment with L-asparaginases indicate that ECAR LANS L-asparaginase suppressed growth of all tested solid tumor cells. Evaluation of leukemic cell number after treatment with L-asparaginases for 24, 48 and 72 h demonstrated that asparagine deficiency did not kill cells but stopped normal cell division. The cytofluorometric study of solid and leukemic cells revealed that except HL-60 cells the treatment with L-asparaginase for 72 h did not change cell cycle phase distribution and did not increase the number of apoptotic cells. Combined treatment of cells using a combination of L-asparaginase and doxorubicin significantly increased the number of apoptotic cells up to 60% (MCF-7 cells), 40% (Jurkat cells) and even 99% (HL-60). High levels of DNA and protein synthesis rates in asparaginase-treated tumor cells suggest lack of massive entry of tumor cells to apoptosis. This conclusion is based on the fact of sensitivity of multi-resistant Jurkat/A4 cells to L-asparaginases (it is nearly impossible to induce apoptosis in these cells). Since ECAR LANS did not influence growth of normal human fibroblasts it appears that the enzyme cytotoxicity is associated only asparagine deficiency.</abstract><cop>Dordrecht</cop><pub>SP MAIK Nauka/Interperiodica</pub><doi>10.1134/S1990750812040026</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1990-7508 |
ispartof | Biochemistry (Moscow). Supplement. Series B, Biomedical chemistry, 2012-10, Vol.6 (4), p.307-316 |
issn | 1990-7508 1990-7516 |
language | eng |
recordid | cdi_proquest_miscellaneous_1285088704 |
source | SpringerLink Journals - AutoHoldings |
subjects | Acute lymphatic leukemia Adenocarcinoma Antitumor activity Apoptosis Asparagine Biochemistry Bioorganic Chemistry Cancer Cell cycle Cell division Cell number Chemistry Chemistry and Materials Science Chemotherapy Chronic myeloid leukemia Cytotoxicity Deoxyribonucleic acid DNA DNA biosynthesis Doxorubicin Enzymes Erwinia carotovora Escherichia coli Fibroblasts Fibrosarcoma Glioblastoma Growth rate L-asparaginase Leukemia Lymphocytes T Medicinal Chemistry Promyeloid leukemia prostate carcinoma Protein biosynthesis Protein synthesis Solid tumors Tumor cell lines Tumor cells |
title | Antitumor activity of L-asparaginase from Erwinia carotovora against different human and animal leukemic and solid tumor cell lines |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T15%3A59%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antitumor%20activity%20of%20L-asparaginase%20from%20Erwinia%20carotovora%20against%20different%20human%20and%20animal%20leukemic%20and%20solid%20tumor%20cell%20lines&rft.jtitle=Biochemistry%20(Moscow).%20Supplement.%20Series%20B,%20Biomedical%20chemistry&rft.au=Abakumova,%20O.%20Yu&rft.date=2012-10-01&rft.volume=6&rft.issue=4&rft.spage=307&rft.epage=316&rft.pages=307-316&rft.issn=1990-7508&rft.eissn=1990-7516&rft_id=info:doi/10.1134/S1990750812040026&rft_dat=%3Cproquest_cross%3E2815149431%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1151799119&rft_id=info:pmid/&rfr_iscdi=true |